Nutex Health reports Q4 results; authorizes stock repurchase program of up to $25M
2026-03-05 23:49:51 ET
More on Nutex Health
- Nutex Health: The $387 Million Receivables Problem And The Legislative Silver Bullet
- Nutex: Stellar Growth But Sustainability Doubts Linger
- Seeking Alpha’s Quant Rating on Nutex Health
- Historical earnings data for Nutex Health
- Financial information for Nutex Health
Read the full article on Seeking Alpha
For further details see:
Nutex Health reports Q4 results; authorizes stock repurchase program of up to $25MNASDAQ: NUTX
NUTX Trading
-11.52% G/L:
$90.64 Last:
502,421 Volume:
$89.05 Open:



